$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

$zvra Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000143774917004317 Filed on March 10, 2017

Income Statement

Concept	2015 Q4	2015 Q3	2015 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.570M	$2.150M	$3.190M
YoY Change	62.66%	97.25%	139.85%
% of Gross Profit
Research & Development	$4.716M	$4.328M	$2.768M
YoY Change	-20.22%	33.05%	61.4%
% of Gross Profit
Depreciation & Amortization	$20.00K	$20.00K	$20.00K
YoY Change	100.0%	0.0%	0.0%
% of Gross Profit
Operating Expenses	$7.282M	$6.480M	$5.956M
YoY Change	-2.75%	49.34%	95.6%
Operating Profit	-$7.282M	-$6.480M	-$5.956M
YoY Change	-2.75%	49.34%	95.6%
Interest Expense	$698.0K	$687.0K	$654.0K
YoY Change	10.62%	297.11%	-7.1%
% of Operating Profit
Other Income/Expense, Net	-$1.922M	-$3.244M	-$23.79M
YoY Change	-55.57%	14.39%	4362.85%
Pretax Income	-$9.204M	-$9.724M	-$29.74M
YoY Change	-22.09%	35.53%	731.27%
Income Tax	-$1.000K	$20.00K
% Of Pretax Income
Net Earnings	-$9.203M	-$9.744M	-$29.74M
YoY Change	-22.28%	36.53%	732.67%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.64	-$0.68	-$2.45
Diluted Earnings Per Share	-$0.64	-$0.68	-$2.45
COMMON SHARES
Basic Shares Outstanding		14.23M	12.16M
Diluted Shares Outstanding			12.16M

Balance Sheet

Concept	2015 Q4	2015 Q3	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.30M	$59.00M	$64.20M
YoY Change	398.06%	210.53%
Cash & Equivalents	$32.32M	$59.01M	$64.22M
Short-Term Investments	$19.00M
Other Short-Term Assets	$2.800M	$600.0K	$600.0K
YoY Change		500.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables	$2.375M
Total Short-Term Assets	$54.08M	$59.60M	$64.83M
YoY Change	426.15%	212.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$403.0K	$400.0K	$352.0K
YoY Change	14.49%	33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$109.0K	$1.400M	$56.00K
YoY Change	-93.25%	-33.33%
Total Long-Term Assets	$512.0K	$1.800M	$1.709M
YoY Change	-85.1%	-25.0%
TOTAL ASSETS
Total Short-Term Assets	$54.08M	$59.60M	$64.83M
Total Long-Term Assets	$512.0K	$1.800M	$1.709M
Total Assets	$54.59M	$61.40M	$66.54M
YoY Change	298.06%	185.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.252M	$4.000M	$4.900M
YoY Change	-20.86%	14.29%
Accrued Expenses	$700.0K
YoY Change	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.400M	$2.800M	$0.00
YoY Change	1600.0%
Total Short-Term Liabilities	$8.342M	$6.792M	$4.910M
YoY Change	111.99%	88.67%
LONG-TERM LIABILITIES
Long-Term Debt	$18.50M	$19.30M	$18.90M
YoY Change	2.21%	9.04%
Other Long-Term Liabilities		$41.10M	$39.30M
YoY Change		223.62%
Total Long-Term Liabilities	$0.00	$60.40M	$58.20M
YoY Change	-100.0%	98.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.342M	$6.792M	$4.910M
Total Long-Term Liabilities	$0.00	$60.40M	$58.20M
Total Liabilities	$64.71M	$67.16M	$63.08M
YoY Change	70.22%	97.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$104.8M	-$95.62M	-$85.88M
YoY Change	108.98%
Common Stock	$94.70M	$89.88M	$89.34M
YoY Change	5625.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.12M	-$5.746M	$3.463M
YoY Change
Total Liabilities & Shareholders Equity	$54.59M	$61.42M	$66.54M
YoY Change	298.06%	185.66%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015 Q2
OPERATING ACTIVITIES
Net Income	-$9.203M	-$9.744M	-$29.74M
YoY Change	-22.28%	36.53%	732.67%
Depreciation, Depletion And Amortization	$20.00K	$20.00K	$20.00K
YoY Change	100.0%	0.0%	0.0%
Cash From Operating Activities	-$6.400M	-$4.620M	-$5.250M
YoY Change	-8.05%	18.77%	79.18%
INVESTING ACTIVITIES
Capital Expenditures	-$40.00K	-$60.00K	-$20.00K
YoY Change	33.33%	500.0%	100.0%
Acquisitions
YoY Change
Other Investing Activities	-$19.00M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$19.04M	-$60.00K	-$20.00K
YoY Change	63366.67%		100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.240M	-550.0K	59.23M
YoY Change	-30.34%	1275.0%	138.45%
NET CHANGE
Cash From Operating Activities	-6.400M	-4.620M	-5.250M
Cash From Investing Activities	-19.04M	-60.00K	-20.00K
Cash From Financing Activities	-1.240M	-550.0K	59.23M
Net Change In Cash	-26.68M	-5.230M	53.96M
YoY Change	204.22%	33.08%	146.39%
FREE CASH FLOW
Cash From Operating Activities	-$6.400M	-$4.620M	-$5.250M
Capital Expenditures	-$40.00K	-$60.00K	-$20.00K
Free Cash Flow	-$6.360M	-$4.560M	-$5.230M
YoY Change	-8.23%	17.53%	79.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2015Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	37839000
CY2016	kmph	Effective Income Tax Rate Reconciliation Conversion Feature And Put Option On Convertible Notes EffectiveIncomeTaxRateReconciliationConversionFeatureAndPutOptionOnConvertibleNotes
CY2015	kmph	Effective Income Tax Rate Reconciliation Conversion Feature And Put Option On Convertible Notes EffectiveIncomeTaxRateReconciliationConversionFeatureAndPutOptionOnConvertibleNotes	-0.0168
CY2014	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	315000
CY2016	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff	445000
CY2015	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff
CY2014	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff
CY2016Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	4618000
CY2015	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup
CY2014	kmph	Effective Income Tax Rate Reconciliation Conversion Feature And Put Option On Convertible Notes EffectiveIncomeTaxRateReconciliationConversionFeatureAndPutOptionOnConvertibleNotes	-0.0126
CY2016	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup	-0.2383
CY2016	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	0.6844
CY2015	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	-0.1528
CY2014	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	-0.0939
CY2016	kmph	Effective Income Tax Rate Reconciliationinterest Expense EffectiveIncomeTaxRateReconciliationinterestExpense
CY2015	kmph	Effective Income Tax Rate Reconciliationinterest Expense EffectiveIncomeTaxRateReconciliationinterestExpense
CY2014	kmph	Effective Income Tax Rate Reconciliationinterest Expense EffectiveIncomeTaxRateReconciliationinterestExpense	0.0021
CY2014	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup	0.0036
CY2014	kmph	Embedded Put Option Allocated To Debt Discount EmbeddedPutOptionAllocatedToDebtDiscount	220000
CY2016	kmph	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises	756000
CY2015	kmph	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises	4293000
CY2016	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	281000
CY2015	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
CY2014	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
CY2016	kmph	Embedded Put Option Allocated To Debt Discount EmbeddedPutOptionAllocatedToDebtDiscount
CY2015	kmph	Embedded Put Option Allocated To Debt Discount EmbeddedPutOptionAllocatedToDebtDiscount
CY2016Q4	kmph	Number Of Manufacturing Arrangement NumberOfManufacturingArrangement	1
CY2016	kmph	Issuance Of Preferred Stock For Transaction Fee IssuanceOfPreferredStockForTransactionFee
CY2015	kmph	Issuance Of Preferred Stock For Transaction Fee IssuanceOfPreferredStockForTransactionFee
CY2014	kmph	Issuance Of Preferred Stock For Transaction Fee IssuanceOfPreferredStockForTransactionFee	1500000
CY2016	kmph	Issuance Of Warrant Allocated To Debt Discount IssuanceOfWarrantAllocatedToDebtDiscount
CY2015	kmph	Issuance Of Warrant Allocated To Debt Discount IssuanceOfWarrantAllocatedToDebtDiscount
CY2014	kmph	Issuance Of Warrant Allocated To Debt Discount IssuanceOfWarrantAllocatedToDebtDiscount	7610000
CY2015Q4	kmph	Other Prepaid Expenses And Current Assets OtherPrepaidExpensesAndCurrentAssets	93000
CY2016	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	600000
CY2015	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	300000
CY2014	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	200000
CY2016Q4	kmph	Other Prepaid Expenses And Current Assets OtherPrepaidExpensesAndCurrentAssets	98000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102643000
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	94702000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6600000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3276000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6600000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	214000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2369000
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1602000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2369000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	214000
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2222000
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2671000
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1114000
CY2016Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	391000
CY2016Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	390000
CY2016Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	393000
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	442000
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1616000
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1909000
CY2015Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	477000
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	477000
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10869947
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5714113
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10430981
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2015Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	475000
CY2015Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	479000
CY2016Q4	us-gaap	Assets Assets	84887000
CY2015Q4	us-gaap	Assets Assets	54590000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	74357000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	54078000
CY2016Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	59203000
CY2015Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	19002000
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26617000
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16390000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3166000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2254000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1793000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	715000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	232000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	83000
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48776000
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29023000
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18096000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	44984000
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	89000
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	80000
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	170000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	89000
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	80000
CY2014Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	170000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	175000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75000
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.45
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.50
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.13
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-7.42
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-10.27
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.45
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.50
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.92
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2575000
CY2014	kmph	Reclassification Of Warrant Liability To Equity ReclassificationOfWarrantLiabilityToEquity
CY2016	kmph	Reclassification Of Warrant Liability To Equity ReclassificationOfWarrantLiabilityToEquity
CY2015	kmph	Reclassification Of Warrant Liability To Equity ReclassificationOfWarrantLiabilityToEquity	1110000
CY2015	kmph	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	4749000
CY2016	kmph	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	896000
CY2016	kmph	Supply Arrangement Automatic Renewal Period SupplyArrangementAutomaticRenewalPeriod	P2Y
CY2016	kmph	Supply Arrangement Expense SupplyArrangementExpense	0
CY2015	kmph	Supply Arrangement Expense SupplyArrangementExpense	0
CY2014	kmph	Supply Arrangement Expense SupplyArrangementExpense	0
CY2016	kmph	Supply Arrangement Period Of Prior Notice SupplyArrangementPeriodOfPriorNotice	P1Y
CY2016	kmph	Trade Receivables TradeReceivables	5003000
CY2015	kmph	Trade Receivables TradeReceivables
CY2014	kmph	Trade Receivables TradeReceivables
CY2016	kmph	Trading Securities Accumulated Loss TradingSecuritiesAccumulatedLoss	-50000
CY2015	kmph	Trading Securities Accumulated Loss TradingSecuritiesAccumulatedLoss	-6000
CY2016	kmph	Transfer Of Warrants To Equity Upon Exercise TransferOfWarrantsToEquityUponExercise	755000
CY2015	kmph	Transfer Of Warrants To Equity Upon Exercise TransferOfWarrantsToEquityUponExercise	4293000
CY2014	kmph	Transfer Of Warrants To Equity Upon Exercise TransferOfWarrantsToEquityUponExercise
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6444000
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4906000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	469000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1252000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5003000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	700000
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	700000
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1024000
CY2015Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	947000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	605000
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	478000
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	157000
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	26000
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	867000
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred
CY2014	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred
CY2016Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	867000
CY2015Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	94000
CY2016Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	836000
CY2015Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	72000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	965000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	214000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	127000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	208000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	208000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	208000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	152000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	813000
CY2016Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	31000
CY2015Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	22000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16762000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32318000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10255000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1969000
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-15556000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22063000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8286000
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12114618
CY2015Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7124961
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14646982
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14490954
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14646982
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14490954
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2381041
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2381041
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; text-indent: 0pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 20.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Financial instruments that potentially expose<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions, the balances of which frequently exceed insured limits.</div></div></div></div></div></div></div>
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	28207000
CY2014	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	91170000
CY2015Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	7412000
CY2016Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent
CY2015Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1369000
CY2016	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
CY2015	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
CY2014	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4159000
CY2016	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2015	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	3276000
CY2014	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	48865000
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29103000
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18266000
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-32465000
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	27276000
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0009
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0002
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0009
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.6931
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1925
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3288
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.1463
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.0315
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1271
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0128
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0142
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0029
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1564
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0406
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0596
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	10600000
CY2016	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y313D
CY2016	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-32465000
CY2015	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	27276000
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7223000
CY2016Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2723000
CY2016Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1299000
CY2016Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-20763000
CY2016Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10278000
CY2015Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	764000
CY2015Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2089000
CY2015Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	22661000
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1762000
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29743000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5967000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15000
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	1110000
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	37839000
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	15966000
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4618000
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-91000
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4740000
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1900000
CY2016Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4740000
CY2015Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14000000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8883000
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4526000
CY2016Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2873000
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3104000
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4287000
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3736000
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2566000
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2152000
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3188000
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	977000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16531000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54638000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24477000
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9940000
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13433000
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9764000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2922000
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9204000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9724000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22000
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19000
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1118000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1315000
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	933000
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	184000
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities
CY2014	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2018000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1228000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-523000
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1100000
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash
CY2016	us-gaap	Interest And Other Income InterestAndOtherIncome	353000
CY2015	us-gaap	Interest And Other Income InterestAndOtherIncome	32000
CY2014	us-gaap	Interest And Other Income InterestAndOtherIncome	8000
CY2016Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	9000
CY2016Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	98000
CY2016Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	144000
CY2016Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	102000
CY2015Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	15000
CY2015Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	11000
CY2015Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	5000
CY2015Q1	us-gaap	Interest And Other Income InterestAndOtherIncome
CY2016	us-gaap	Interest Expense InterestExpense	5511000
CY2015	us-gaap	Interest Expense InterestExpense	2671000
CY2014	us-gaap	Interest Expense InterestExpense	1605000
CY2016Q4	us-gaap	Interest Expense InterestExpense	1445000
CY2016Q3	us-gaap	Interest Expense InterestExpense	1441000
CY2016Q2	us-gaap	Interest Expense InterestExpense	1475000
CY2016Q1	us-gaap	Interest Expense InterestExpense	1150000
CY2015Q4	us-gaap	Interest Expense InterestExpense	698000
CY2015Q3	us-gaap	Interest Expense InterestExpense	687000
CY2015Q2	us-gaap	Interest Expense InterestExpense	654000
CY2015Q1	us-gaap	Interest Expense InterestExpense	632000
CY2016	us-gaap	Interest Paid InterestPaid	3289000
CY2015	us-gaap	Interest Paid InterestPaid
CY2014	us-gaap	Interest Paid InterestPaid	3000
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2222000
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	698000
CY2016Q4	us-gaap	Liabilities Liabilities	103583000
CY2015Q4	us-gaap	Liabilities Liabilities	64711000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84887000
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54590000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6642000
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8342000
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	4618000
CY2015Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	37839000
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	8200000
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments
CY2016Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2015Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	20000
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	51003000
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	19002000
CY2016Q4	us-gaap	Mediumterm Notes Current MediumtermNotesCurrent
CY2015Q4	us-gaap	Mediumterm Notes Current MediumtermNotesCurrent	2041000
CY2016Q4	us-gaap	Mediumterm Notes Noncurrent MediumtermNotesNoncurrent
CY2015Q4	us-gaap	Mediumterm Notes Noncurrent MediumtermNotesNoncurrent	11118000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	61163000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	61468000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	23004000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-46947000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-19137000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-47000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-29772000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-20268000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-14671000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-16516000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-54664000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-24455000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-9936000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-13414000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	9768000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-2934000
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20951000
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-9203000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-9744000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-29743000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-5974000
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31824000
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8034000
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	896000
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3032000
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19039000
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4048000
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1922000
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3244000
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23787000
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2871000
CY2016	us-gaap	Operating Expenses OperatingExpenses	37482000
CY2015	us-gaap	Operating Expenses OperatingExpenses	22814000
CY2014	us-gaap	Operating Expenses OperatingExpenses	16443000
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	10836000
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	10401000
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	9275000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	6970000
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	7282000
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	6480000
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	5956000
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	3096000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-37482000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-22814000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-16443000
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-10836000
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10401000
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9275000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6970000
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7282000
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6480000
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5956000
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3096000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4493000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	555000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	449000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	499000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	569000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	585000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1836000
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	103364000
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1383000
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1309000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	360000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	109000
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	41000
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	881000
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1153000
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent
CY2016Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	58000
CY2015Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2375000
CY2016	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	983000
CY2015	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	2533000
CY2014	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	163000
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	164000
CY2015	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	315000
CY2014	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1767000
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	89849000
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19002000
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	643000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	135000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47000
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	489000
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2758000
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	333000
CY2015Q4	us-gaap	Prepaid Insurance PrepaidInsurance	290000
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclas<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">sifications</div></div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">, the Company adopted Accounting Standards Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03,</div> <div style="display: inline; font-style: italic;">Interest – Imputation of Interest (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">835</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30)</div></div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03”),</div> which requires the debt issuance costs related to a recognized debt liability be presented in the balance sheet as direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt discounts. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> reduced the Company’s assets and liabilities by the amount of the debt issuance costs, which was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div> million at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> This reclassification had no effect on reported net loss or cash flows.</div></div></div></div></div></div></div>
CY2016	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering
CY2015	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	59892000
CY2014	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering
CY2016	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	82800000
CY2015	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt
CY2014	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	25000000
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	44645000
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	141000
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	413000
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1970000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	403000
CY2016	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1931000
CY2015	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2014	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit
CY2015	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit
CY2014	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	35000
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	79000
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	32000
CY2014	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	31000
CY2016	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18621000
CY2015	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2014	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20472000
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13931000
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11917000
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7963000
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4287000
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4988000
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3234000
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4716000
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4328000
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2768000
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2119000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1100000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue
CY2016	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	3
CY2016Q4	us-gaap	Restructuring Charges RestructuringCharges
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	3010000
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges
CY2015Q4	us-gaap	Restructuring Charges RestructuringCharges
CY2015Q3	us-gaap	Restructuring Charges RestructuringCharges
CY2015Q2	us-gaap	Restructuring Charges RestructuringCharges
CY2015Q1	us-gaap	Restructuring Charges RestructuringCharges
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	646000
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121340000
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-104824000
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	351693
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	26400
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	959375
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9204403
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26400
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1397511
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.31
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y284D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1990260
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.28
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1352768
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1013424
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y211D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y98D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y98D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5400000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1100000
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	200000
CY2016	us-gaap	Severance Costs1 SeveranceCosts1	3010000
CY2015	us-gaap	Severance Costs1 SeveranceCosts1
CY2014	us-gaap	Severance Costs1 SeveranceCosts1
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	6600000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2369000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	214000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	637492
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.77
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	169000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	54000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.64
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	26400
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1978260
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	13.62
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.78
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.65
CY2016Q4	us-gaap	Trading Securities TradingSecurities	50400000
CY2015Q4	us-gaap	Trading Securities TradingSecurities	10100000
CY2015Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	1100000
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	13333
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	163998
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	9.25
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	10.63
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.50
CY2016	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	15000
CY2015	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	15000
CY2014	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	22000
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14933
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4766
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	59892000
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	71000
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-18696000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-10121000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-24267000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-48508000
CY2015Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	7.5
CY2015Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding
CY2016Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP")<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, includ<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ing those related to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div></div></div>
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14597053
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7368681
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2381041
CY2015	kmph	Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering Value ConversionOfPreferredStockToCommonStockUponInitialPublicOfferingValue	28207000
CY2016Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	48776000
CY2015Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	29023000
CY2014Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	18096000
CY2016Q2	dei	Entity Public Float EntityPublicFloat	46412563
CY2016	kmph	Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts	445000
CY2015	kmph	Adjustments To Additional Paid In Capital Conversion Of Warrants To Equity Classification AdjustmentsToAdditionalPaidInCapitalConversionOfWarrantsToEquityClassification	1110000
CY2016	kmph	Common Stock Issued During Period From Warrants Exercised CommonStockIssuedDuringPeriodFromWarrantsExercised	141095
CY2015	kmph	Common Stock Issued During Period From Warrants Exercised CommonStockIssuedDuringPeriodFromWarrantsExercised	270038
CY2014	kmph	Common Stock Issued During Period From Warrants Exercised CommonStockIssuedDuringPeriodFromWarrantsExercised	0
CY2015	kmph	Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering Shares ConversionOfPreferredStockToCommonStockUponInitialPublicOfferingShares	5980564
CY2015	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	428000
CY2016	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	85000

Files In Submission

Name	View Source	Status
0001437749-17-004317-index-headers.html	Edgar Link	pending
0001437749-17-004317-index.html	Edgar Link	pending
0001437749-17-004317.txt	Edgar Link	pending
0001437749-17-004317-xbrl.zip	Edgar Link	pending
ex10-28.htm	Edgar Link	pending
ex10-29.htm	Edgar Link	pending
ex10-29img006.gif	Edgar Link	pending
ex10-30.htm	Edgar Link	pending
ex10-31.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kmph-20161231.xml	Edgar Link	completed
kmph-20161231.xsd	Edgar Link	pending
kmph-20161231_cal.xml	Edgar Link	unprocessable
kmph-20161231_def.xml	Edgar Link	unprocessable
kmph-20161231_lab.xml	Edgar Link	unprocessable
kmph-20161231_pre.xml	Edgar Link	unprocessable
kmph20161231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

2015 Q4 Form 10-K Financial Statement

#000143774917004317 Filed on March 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA ZEVRA THERAPEUTICS, INC. Stock $zvra

2015 Q4 Form 10-K Financial Statement

#000143774917004317 Filed on March 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra